# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051325
Filing Date
2020-11-05
Accepted
2020-11-05 16:16:43
Documents
82
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-10q_20200930.htm iXBRL | 10-Q | 3434717
2 | EX-10.2 | dvax-ex102_355.htm | EX-10.2 | 307021
3 | EX-10.3 | dvax-ex103_247.htm | EX-10.3 | 88543
4 | EX-10.4 | dvax-ex104_248.htm | EX-10.4 | 74630
5 | EX-31.1 | dvax-ex311_9.htm | EX-31.1 | 17838
6 | EX-31.2 | dvax-ex312_12.htm | EX-31.2 | 17779
7 | EX-32.1 | dvax-ex321_8.htm | EX-32.1 | 6094
8 | EX-32.2 | dvax-ex322_7.htm | EX-32.2 | 6332
| Complete submission text file | 0001564590-20-051325.txt |  | 12617799

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | dvax-20200930.xsd | EX-101.SCH | 71276
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dvax-20200930_cal.xml | EX-101.CAL | 70915
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dvax-20200930_def.xml | EX-101.DEF | 287177
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dvax-20200930_lab.xml | EX-101.LAB | 566393
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dvax-20200930_pre.xml | EX-101.PRE | 449221
14 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-10q_20200930_htm.xml | XML | 2437506

Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 201290664
SIC: 2834 Pharmaceutical Preparations